Form 8-K - Current report:
SEC Accession No. 0001842952-24-000083
Filing Date
2024-09-23
Accepted
2024-09-23 07:33:19
Documents
60
Period of Report
2024-09-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cntx-20240923.htm   iXBRL 8-K 36819
2 EX-10.1 bioatla-contexttherapeutic.htm EX-10.1 363747
3 EX-99.1 a2024-09x23xxbcabxxexclusi.htm EX-99.1 22038
4 EX-99.2 a2024sept-contextxcorpde.htm EX-99.2 48236
8 a2024sept-contextxcorpde001.jpg GRAPHIC 54250
9 a2024sept-contextxcorpde002.jpg GRAPHIC 216291
10 a2024sept-contextxcorpde003.jpg GRAPHIC 114785
11 a2024sept-contextxcorpde004.jpg GRAPHIC 101291
12 a2024sept-contextxcorpde005.jpg GRAPHIC 98157
13 a2024sept-contextxcorpde006.jpg GRAPHIC 66619
14 a2024sept-contextxcorpde007.jpg GRAPHIC 79102
15 a2024sept-contextxcorpde008.jpg GRAPHIC 114586
16 a2024sept-contextxcorpde009.jpg GRAPHIC 97261
17 a2024sept-contextxcorpde010.jpg GRAPHIC 77503
18 a2024sept-contextxcorpde011.jpg GRAPHIC 67590
19 a2024sept-contextxcorpde012.jpg GRAPHIC 115441
20 a2024sept-contextxcorpde013.jpg GRAPHIC 116597
21 a2024sept-contextxcorpde014.jpg GRAPHIC 85637
22 a2024sept-contextxcorpde015.jpg GRAPHIC 110140
23 a2024sept-contextxcorpde016.jpg GRAPHIC 96879
24 a2024sept-contextxcorpde017.jpg GRAPHIC 131168
25 a2024sept-contextxcorpde018.jpg GRAPHIC 98143
26 a2024sept-contextxcorpde019.jpg GRAPHIC 88053
27 a2024sept-contextxcorpde020.jpg GRAPHIC 67202
28 a2024sept-contextxcorpde021.jpg GRAPHIC 107376
29 a2024sept-contextxcorpde022.jpg GRAPHIC 111050
30 a2024sept-contextxcorpde023.jpg GRAPHIC 104904
31 a2024sept-contextxcorpde024.jpg GRAPHIC 89392
32 a2024sept-contextxcorpde025.jpg GRAPHIC 93186
33 a2024sept-contextxcorpde026.jpg GRAPHIC 103674
34 a2024sept-contextxcorpde027.jpg GRAPHIC 128512
35 a2024sept-contextxcorpde028.jpg GRAPHIC 89665
36 a2024sept-contextxcorpde029.jpg GRAPHIC 91793
37 a2024sept-contextxcorpde030.jpg GRAPHIC 67616
38 a2024sept-contextxcorpde031.jpg GRAPHIC 108317
39 a2024sept-contextxcorpde032.jpg GRAPHIC 125819
40 a2024sept-contextxcorpde033.jpg GRAPHIC 110281
41 a2024sept-contextxcorpde034.jpg GRAPHIC 105173
42 a2024sept-contextxcorpde035.jpg GRAPHIC 96418
43 a2024sept-contextxcorpde036.jpg GRAPHIC 97194
44 a2024sept-contextxcorpde037.jpg GRAPHIC 64481
45 a2024sept-contextxcorpde038.jpg GRAPHIC 83165
46 a2024sept-contextxcorpde039.jpg GRAPHIC 65259
47 a2024sept-contextxcorpde040.jpg GRAPHIC 59557
48 a2024sept-contextxcorpde041.jpg GRAPHIC 51676
49 a2024sept-contextxcorpde042.jpg GRAPHIC 96156
50 image_0.jpg GRAPHIC 46410
51 image_1.jpg GRAPHIC 36786
  Complete submission text file 0001842952-24-000083.txt   6396590

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntx-20240923.xsd EX-101.SCH 1937
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntx-20240923_lab.xml EX-101.LAB 24372
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntx-20240923_pre.xml EX-101.PRE 14143
62 EXTRACTED XBRL INSTANCE DOCUMENT cntx-20240923_htm.xml XML 3001
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40654 | Film No.: 241314642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)